SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-283050
Filing Date
2015-08-07
Accepted
2015-08-07 16:04:15
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d936795d10q.htm 10-Q 249324
2 EX-31.1 d936795dex311.htm EX-31.1 6733
3 EX-31.2 d936795dex312.htm EX-31.2 6965
4 EX-32.1 d936795dex321.htm EX-32.1 3373
5 EX-32.2 d936795dex322.htm EX-32.2 3622
  Complete submission text file 0001193125-15-283050.txt   1968089

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cnat-20150630.xml EX-101.INS 300292
7 XBRL TAXONOMY EXTENSION SCHEMA cnat-20150630.xsd EX-101.SCH 22760
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cnat-20150630_cal.xml EX-101.CAL 41426
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnat-20150630_def.xml EX-101.DEF 72782
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnat-20150630_lab.xml EX-101.LAB 225620
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnat-20150630_pre.xml EX-101.PRE 153398
Mailing Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127
Business Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127 (858) 376-2600
Conatus Pharmaceuticals Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36003 | Film No.: 151037313
SIC: 2834 Pharmaceutical Preparations